Latest Biotech News

A population-based cohort study published in the Canadian Medical Association Journal identifies a significant association between traumatic brain injuries in adults over 65 and heightened...

The third quarter of 2025 saw 62 biopharma layoff rounds, closely mirroring previous quarterly figures and positioning 2025 to exceed 2024’s total workforce reductions. Major companies such as...

The U.S. Food and Drug Administration initiated a new pilot program aimed at accelerating the regulatory review of generic drugs manufactured and tested in the United States using domestically...

Regencell Bioscience Holdings, a small Hong Kong-based biotech focused on traditional Chinese medicine treatments for neurocognitive disorders, experienced an unprecedented stock surge of up to...

The biopharmaceutical sector recorded 62 layoff rounds in the third quarter of 2025, reflecting a continuation of a challenging employment environment. Major companies including Novo Nordisk,...

Medtronic in collaboration with UCSF researchers, led by Maria Shcherbakova, has developed adaptive deep brain stimulation technology that automatically adjusts brain implants in real time to...

Researchers have introduced EDG-PPIS, an equivariant and dual-scale graph network framework designed to improve prediction accuracy of protein–protein interaction sites. This advancement in...

An innovative study integrates artificial neural networks with hyperspectral imaging to enhance prognostic assessments in esophageal adenocarcinoma. This approach enables detailed analysis of...

Dovetail Genomics has introduced LinkPrep™, a technology that simultaneously reads DNA sequence and genome 3D architecture, providing insights into structural variants and regulatory disruptions...

FDA leaders from CDER and CBER are scheduled to meet with key industry groups including BIO and PhRMA to discuss the reauthorization of the Prescription Drug User Fee Act (PDUFA). These...

The Trump administration is completing the final review of a Medicare Part D rule implementing a Most Favored Nation (MFN) pricing model. This regulatory change aims to align Medicare drug prices...

New research from Mass General Brigham assesses the utility of over-the-counter continuous glucose monitors (CGMs) in individuals without diabetes and finds limited clinical benefit. While CGMs...

Regencell Bioscience Holdings, a Hong Kong biotech focused on Traditional Chinese Medicine for neurocognitive disorders, experienced an extraordinary stock price surge of up to 82,000% YTD in...

The biopharma industry recorded 62 layoff rounds in Q3 2025, consistent with previous quarters and on track to surpass 2024's total by 27%. Notably, Novo Nordisk cut 9,000 jobs, Merck eliminated...

CDER and CBER leaders at the FDA are scheduled to meet with industry groups BIO and PhRMA to discuss the Prescription Drug User Fee Act (PDUFA) reauthorization. The talks will focus on leveraging...

Recent innovations in artificial intelligence and computational modeling are reshaping biotech. Notable developments include emergent deep learning frameworks improving protein interaction...

Recent studies reveal critical molecular mechanisms influencing cancer aggressiveness and therapeutic response. Highlights include identification of metabolic activity of visceral fat driving...

Studies continue to explore the biomedical potential of Traditional Chinese Medicine (TCM). Regencell’s TCM formulations for neurocognitive disorders attracted speculative finance. Separately,...

Recent pediatric research highlights improvements in clinical care. Innovations include advances in pediatric flexible bronchoscopy techniques, meta-analytical evidence cautioning against...

Multiple studies examine nursing workforce issues. Research reveals the impact of abusive supervision on nurses leading to deviant acts, the importance of psychological resilience in nursing...